Ranbaxy Laboratories has secured approval from India's Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell 'Synriam' to treat uncomplicated malaria caused by Plasmodium vivax parasite in adult patients. Phase III ...
Tags: Ranbaxy Laboratories, Drug Synriam
Ranbaxy Laboratories has unveiled Synriam in India, to treat uncomplicated Plasmodium falciparum malaria, in adults. The Drug Controller General of India approved the new drug, indicated for relief from malaria-related symptoms, for ...
Tags: Malaria Drug, Synriam, malaria